RESEARCHER PROFILE (Filmed November 2023)
Dr Brendan Shannon
Head of Postgraduate Programs
Monash University
Melbourne, Australia
Dr Brendan Shannon is a registered paramedic and Head of Postgraduate Programs and Deputy Head of Department of Paramedicine at Monash University.
Transitioning from 12 years clinical work as a paramedic to academia, Dr. Brendan Shannon understands the importance of research and education in the field of healthcare. He became a paramedic, pursued higher education, and transitioned into academia while still maintaining a clinical workload.
Brendan has balanced clinical and academic experience throughout his career and his research is closely informed by paramedicine practice.
Brendan has a keen research interest in alternative care pathways, non-transport, referral services, paramedic practitioners and community paramedicine. His Doctoral research focused on investigating the experiences of health services when implementing alternative care pathways.
These pathways are designed to deliver care in community settings for populations that are traditionally underserved. The programs examined were found to effectively address complex patients’ needs in community settings.
Dr. Shannon is driven to help people’s lives be better, particularly those who don’t have the privileges as others. His focus is on treating underserved communities with chronic diseases and complex social conditions, who frequently use healthcare services, through community paramedicine programs, as well as patients who frequently utilise healthcare services like the emergency department.
“The intersection of chronic disease and complex social conditions presents a unique challenge in healthcare. Researching programs to increase access to care for underserved patients within the community is a big umbrella term with lots of avenues to explore”, says Dr Shannon.
Apart from research, having a purpose to help others and teaching, Dr Shannon has a passion for restoring old cars nurtured from family influences. He also takes part in amateur martial arts, in particular Brazilian jiu-jitsu.
-
Mechanisms of resistance to menin inhibitor therapy and Acute Myeloid Leukaemia
Dr Rithin Nedumannil (MBBS, MPH, FRACP, FRCPA) is a PhD candidate at the University of Melbourne, undertaking his doctoral studies in collaboration with the Cambridge Stem Cell Institute (Cambridge, UK) and the Peter MacCallum Cancer Centre (Melbourne, Australia). He is a clinical haematologist and haematopathologist with current appointments at Peter MacCallum Cancer Centre, the Royal Melbourne Hospital, Austin Health and Northern Health.
-
Unnecessary tests and treatments in low value critical care
Dr Gerben Keijzers is a Senior Staff Specialist Emergency Physician at the Gold Coast University Hospital Emergency Department. His research focus includes low-value care, which is in the area of unnecessary tests and treatments with minimal benefits. Dr Keijzers has contributed to over 100 publications and more than 20 grant applications. Through his involvement in multi-site collaborative research projects, he encourages critical thinking and curiosity among clinical staff, striving to enhance both patient care and the efficiency of healthcare resources.
-
Targeting chemotherapy resistance in ovarian cancer patients
Dr Alex Cole, from the Centenary Institute’s Centre for Biomedical AI, is now leading the research focused on developing a new treatment to counteract a protein called follistatin (FST), known for making ovarian cancer cells resistant to chemotherapy.
By employing cutting-edge molecular biology and directed evolution techniques, the project aims to create nanobodies—small, precise molecules—that can block FST. If successful, these nanobodies could enhance the effectiveness of chemotherapy and improve ovarian cancer treatment rates.
